ID   ARBK1_HUMAN             Reviewed;         689 AA.
AC   P25098; B0ZBE1; Q13837; Q6GTT3;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   15-MAR-2017, entry version 191.
DE   RecName: Full=Beta-adrenergic receptor kinase 1;
DE            Short=Beta-ARK-1;
DE            EC=2.7.11.15;
DE   AltName: Full=G-protein coupled receptor kinase 2 {ECO:0000312|HGNC:HGNC:289};
GN   Name=GRK2 {ECO:0000312|HGNC:HGNC:289}; Synonyms=ADRBK1, BARK, BARK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2037065; DOI=10.1016/0014-5793(91)80568-N;
RA   Benovic J.L., Stone W.C., Huebner K., Croce C., Caron M.G.,
RA   Lefkowitz R.J.;
RT   "cDNA cloning and chromosomal localization of the human beta-
RT   adrenergic receptor kinase.";
RL   FEBS Lett. 283:122-126(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=1339451;
RA   Chuang T.T., Sallese M., Ambrosini G., Parruti G., de Blasi A.;
RT   "High expression of beta-adrenergic receptor kinase in human
RT   peripheral blood leukocytes. Isoproterenol and platelet activating
RT   factor can induce kinase translocation.";
RL   J. Biol. Chem. 267:6886-6892(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8195124;
RA   Penn R.B., Benovic J.L.;
RT   "Structure of the human gene encoding the beta-adrenergic receptor
RT   kinase.";
RL   J. Biol. Chem. 269:14924-14930(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH ARRB1.
RX   PubMed=9501202; DOI=10.1073/pnas.95.6.2985;
RA   Aragay A.M., Mellado M., Frade J.M., Martin A.M., Jimenez-Sainz M.C.,
RA   Martinez-A C., Mayor F. Jr.;
RT   "Monocyte chemoattractant protein-1-induced CCR2B receptor
RT   desensitization mediated by the G protein-coupled receptor kinase 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2985-2990(1998).
RN   [7]
RP   INTERACTION WITH CCR5, AND TISSUE SPECIFICITY.
RX   PubMed=10085131; DOI=10.1074/jbc.274.13.8875;
RA   Oppermann M., Mack M., Proudfoot A.E., Olbrich H.;
RT   "Differential effects of CC chemokines on CC chemokine receptor 5
RT   (CCR5) phosphorylation and identification of phosphorylation sites on
RT   the CCR5 carboxyl terminus.";
RL   J. Biol. Chem. 274:8875-8885(1999).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH LPAR1; LPAR2 AND RALA.
RX   PubMed=19306925; DOI=10.1016/j.cellsig.2009.03.011;
RA   Aziziyeh A.I., Li T.T., Pape C., Pampillo M., Chidiac P.,
RA   Possmayer F., Babwah A.V., Bhattacharya M.;
RT   "Dual regulation of lysophosphatidic acid (LPA1) receptor signalling
RT   by Ral and GRK.";
RL   Cell. Signal. 21:1207-1217(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   STRUCTURE BY NMR OF 552-670.
RX   PubMed=9446593; DOI=10.1074/jbc.273.5.2835;
RA   Fushman D., Najmabadi-Haske T., Cahill S., Zheng J., Levine H. III,
RA   Cowburn D.;
RT   "The solution structure and dynamics of the pleckstrin homology domain
RT   of G protein-coupled receptor kinase 2 (beta-adrenergic receptor
RT   kinase 1). A binding partner of Gbetagamma subunits.";
RL   J. Biol. Chem. 273:2835-2843(1998).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-184 AND GLN-578.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Specifically phosphorylates the agonist-occupied form of
CC       the beta-adrenergic and closely related receptors, probably
CC       inducing a desensitization of them. Key regulator of LPAR1
CC       signaling. Competes with RALA for binding to LPAR1 thus affecting
CC       the signaling properties of the receptor. Desensitizes LPAR1 and
CC       LPAR2 in a phosphorylation-independent manner.
CC       {ECO:0000269|PubMed:19306925}.
CC   -!- CATALYTIC ACTIVITY: ATP + [beta-adrenergic receptor] = ADP +
CC       [beta-adrenergic receptor] phosphate.
CC   -!- ENZYME REGULATION: In contrast to other AGC family kinases, the
CC       catalytic activity is solely regulated by the binding of
CC       substrates and ligands, not by phosphorylation of the kinase
CC       domain. {ECO:0000250|UniProtKB:P21146}.
CC   -!- SUBUNIT: Interacts with GIT1 (By similarity). Interacts with, and
CC       phosphorylates chemokine-stimulated CCR5. Interacts with ARRB1.
CC       Interacts with LPAR1 and LPAR2. Interacts with RALA in response to
CC       LPAR1 activation. ADRBK1 and RALA mutually inhibit each other's
CC       binding to LPAR1. {ECO:0000250, ECO:0000269|PubMed:10085131,
CC       ECO:0000269|PubMed:19306925, ECO:0000269|PubMed:9501202}.
CC   -!- INTERACTION:
CC       P21462:FPR1; NbExp=3; IntAct=EBI-3904795, EBI-2869495;
CC       Q9Y2X7:GIT1; NbExp=5; IntAct=EBI-3904795, EBI-466061;
CC       Q00987:MDM2; NbExp=4; IntAct=EBI-3904795, EBI-389668;
CC       P0CG48:UBC; NbExp=3; IntAct=EBI-3904795, EBI-3390054;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P21146}.
CC       Cell membrane {ECO:0000250|UniProtKB:P21146}.
CC   -!- TISSUE SPECIFICITY: Expressed in peripheral blood leukocytes.
CC       {ECO:0000269|PubMed:10085131}.
CC   -!- DOMAIN: The PH domain binds anionic phospholipids and helps
CC       recruiting ADRBK1 from the cytoplasm to plasma membrane close to
CC       activated receptors. It mediates binding to G protein beta and
CC       gamma subunits, competing with G-alpha subunits and other G-
CC       betagamma effectors. {ECO:0000250|UniProtKB:P21146}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. GPRK subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Beta adrenergic receptor kinase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Beta_Adrenergic_Receptor_Kinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61157; CAA43470.1; -; mRNA.
DR   EMBL; M80776; AAA58391.1; -; mRNA.
DR   EMBL; U08438; AAB60689.1; -; Genomic_DNA.
DR   EMBL; U08435; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; U08436; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; U08437; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; EU326303; ACA05909.1; -; Genomic_DNA.
DR   EMBL; BC037963; AAH37963.1; -; mRNA.
DR   EMBL; BC090863; AAH90863.1; -; mRNA.
DR   CCDS; CCDS8156.1; -.
DR   PIR; A53791; A53791.
DR   RefSeq; NP_001610.2; NM_001619.3.
DR   UniGene; Hs.83636; -.
DR   PDB; 1BAK; NMR; -; A=556-670.
DR   PDB; 3CIK; X-ray; 2.75 A; A=1-689.
DR   PDB; 3KRW; X-ray; 2.90 A; A=2-689.
DR   PDB; 3KRX; X-ray; 3.10 A; A=2-689.
DR   PDB; 3V5W; X-ray; 2.07 A; A=1-689.
DR   PDB; 4MK0; X-ray; 2.40 A; A=30-668.
DR   PDB; 4PNK; X-ray; 2.56 A; A=1-689.
DR   PDB; 5HE1; X-ray; 3.15 A; A=29-670.
DR   PDBsum; 1BAK; -.
DR   PDBsum; 3CIK; -.
DR   PDBsum; 3KRW; -.
DR   PDBsum; 3KRX; -.
DR   PDBsum; 3V5W; -.
DR   PDBsum; 4MK0; -.
DR   PDBsum; 4PNK; -.
DR   PDBsum; 5HE1; -.
DR   ProteinModelPortal; P25098; -.
DR   SMR; P25098; -.
DR   BioGrid; 106665; 55.
DR   DIP; DIP-42429N; -.
DR   IntAct; P25098; 22.
DR   MINT; MINT-1214643; -.
DR   STRING; 9606.ENSP00000312262; -.
DR   BindingDB; P25098; -.
DR   ChEMBL; CHEMBL4079; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   GuidetoPHARMACOLOGY; 1466; -.
DR   iPTMnet; P25098; -.
DR   PhosphoSitePlus; P25098; -.
DR   BioMuta; ADRBK1; -.
DR   DMDM; 126302521; -.
DR   EPD; P25098; -.
DR   MaxQB; P25098; -.
DR   PaxDb; P25098; -.
DR   PeptideAtlas; P25098; -.
DR   PRIDE; P25098; -.
DR   DNASU; 156; -.
DR   Ensembl; ENST00000308595; ENSP00000312262; ENSG00000173020.
DR   GeneID; 156; -.
DR   KEGG; hsa:156; -.
DR   UCSC; uc009yrn.2; human.
DR   CTD; 156; -.
DR   DisGeNET; 156; -.
DR   GeneCards; GRK2; -.
DR   HGNC; HGNC:289; GRK2.
DR   HPA; CAB005021; -.
DR   HPA; CAB037248; -.
DR   HPA; HPA048330; -.
DR   MIM; 109635; gene.
DR   neXtProt; NX_P25098; -.
DR   OpenTargets; ENSG00000173020; -.
DR   PharmGKB; PA40; -.
DR   eggNOG; KOG0986; Eukaryota.
DR   eggNOG; ENOG410YRQZ; LUCA.
DR   GeneTree; ENSGT00860000133699; -.
DR   HOGENOM; HOG000006742; -.
DR   HOVERGEN; HBG050559; -.
DR   InParanoid; P25098; -.
DR   KO; K00910; -.
DR   OMA; LMEFYEE; -.
DR   OrthoDB; EOG091G0AEI; -.
DR   PhylomeDB; P25098; -.
DR   TreeFam; TF313940; -.
DR   BRENDA; 2.7.11.15; 2681.
DR   Reactome; R-HSA-111933; Calmodulin induced events.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-5635838; Activation of SMO.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   SignaLink; P25098; -.
DR   SIGNOR; P25098; -.
DR   ChiTaRS; ADRBK1; human.
DR   EvolutionaryTrace; P25098; -.
DR   GeneWiki; Beta_adrenergic_receptor_kinase; -.
DR   GenomeRNAi; 156; -.
DR   PRO; PR:P25098; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000173020; -.
DR   CleanEx; HS_ADRBK1; -.
DR   ExpressionAtlas; P25098; baseline and differential.
DR   Genevisible; P25098; HS.
DR   GO; GO:0005929; C:cilium; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031694; F:alpha-2A adrenergic receptor binding; ISS:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047696; F:beta-adrenergic receptor kinase activity; TAS:Reactome.
DR   GO; GO:0031755; F:Edg-2 lysophosphatidic acid receptor binding; IDA:UniProtKB.
DR   GO; GO:0004703; F:G-protein coupled receptor kinase activity; ISS:BHF-UCL.
DR   GO; GO:0004672; F:protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002029; P:desensitization of G-protein coupled receptor protein signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0045988; P:negative regulation of striated muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0003108; P:negative regulation of the force of heart contraction by chemical signal; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0033605; P:positive regulation of catecholamine secretion; ISS:BHF-UCL.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0007217; P:tachykinin receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:CACAO.
DR   GO; GO:0019079; P:viral genome replication; IMP:CACAO.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000239; GPCR_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR00717; GPCRKINASE.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00315; RGS; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    689       Beta-adrenergic receptor kinase 1.
FT                                /FTId=PRO_0000085627.
FT   DOMAIN       54    175       RGS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00171}.
FT   DOMAIN      191    453       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      454    521       AGC-kinase C-terminal.
FT   DOMAIN      558    652       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   NP_BIND     197    205       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1    190       N-terminal.
FT   ACT_SITE    317    317       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     220    220       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     670    670       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     184    184       I -> T (in dbSNP:rs55696045).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040378.
FT   VARIANT     578    578       R -> Q (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040379.
FT   CONFLICT    168    185       SDKFTRFCQWKNVELNIH -> RISSHGFASGRMWSSTST
FT                                (in Ref. 3; AAB60689). {ECO:0000305}.
FT   CONFLICT    211    211       A -> R (in Ref. 1; CAA43470 and 3;
FT                                AAB60689). {ECO:0000305}.
FT   CONFLICT    422    422       R -> H (in Ref. 1; CAA43470 and 3;
FT                                AAB60689). {ECO:0000305}.
FT   CONFLICT    465    465       K -> R (in Ref. 1; CAA43470).
FT                                {ECO:0000305}.
FT   HELIX        39     49       {ECO:0000244|PDB:3V5W}.
FT   HELIX        55     59       {ECO:0000244|PDB:3V5W}.
FT   HELIX        62     75       {ECO:0000244|PDB:3V5W}.
FT   HELIX        77     79       {ECO:0000244|PDB:3V5W}.
FT   HELIX        80     93       {ECO:0000244|PDB:3V5W}.
FT   HELIX        98    109       {ECO:0000244|PDB:3V5W}.
FT   HELIX       112    118       {ECO:0000244|PDB:3V5W}.
FT   STRAND      119    122       {ECO:0000244|PDB:3V5W}.
FT   HELIX       126    137       {ECO:0000244|PDB:3V5W}.
FT   TURN        143    146       {ECO:0000244|PDB:3V5W}.
FT   HELIX       147    157       {ECO:0000244|PDB:3V5W}.
FT   HELIX       160    167       {ECO:0000244|PDB:3V5W}.
FT   HELIX       169    181       {ECO:0000244|PDB:3V5W}.
FT   HELIX       188    190       {ECO:0000244|PDB:3V5W}.
FT   STRAND      191    199       {ECO:0000244|PDB:3V5W}.
FT   STRAND      201    210       {ECO:0000244|PDB:3V5W}.
FT   TURN        211    213       {ECO:0000244|PDB:3V5W}.
FT   STRAND      216    223       {ECO:0000244|PDB:3V5W}.
FT   HELIX       224    229       {ECO:0000244|PDB:3V5W}.
FT   HELIX       233    246       {ECO:0000244|PDB:3V5W}.
FT   STRAND      247    249       {ECO:0000244|PDB:3V5W}.
FT   STRAND      252    254       {ECO:0000244|PDB:3KRW}.
FT   STRAND      257    262       {ECO:0000244|PDB:3V5W}.
FT   STRAND      264    271       {ECO:0000244|PDB:3V5W}.
FT   STRAND      276    278       {ECO:0000244|PDB:5HE1}.
FT   HELIX       279    286       {ECO:0000244|PDB:3V5W}.
FT   HELIX       291    309       {ECO:0000244|PDB:3V5W}.
FT   TURN        310    312       {ECO:0000244|PDB:3V5W}.
FT   HELIX       320    322       {ECO:0000244|PDB:3V5W}.
FT   STRAND      323    325       {ECO:0000244|PDB:3V5W}.
FT   STRAND      331    333       {ECO:0000244|PDB:3V5W}.
FT   HELIX       336    338       {ECO:0000244|PDB:3CIK}.
FT   STRAND      343    345       {ECO:0000244|PDB:4MK0}.
FT   HELIX       354    356       {ECO:0000244|PDB:3V5W}.
FT   HELIX       359    362       {ECO:0000244|PDB:3V5W}.
FT   HELIX       371    386       {ECO:0000244|PDB:3V5W}.
FT   HELIX       393    395       {ECO:0000244|PDB:3V5W}.
FT   HELIX       399    408       {ECO:0000244|PDB:3V5W}.
FT   STRAND      415    417       {ECO:0000244|PDB:3KRW}.
FT   HELIX       419    428       {ECO:0000244|PDB:3V5W}.
FT   HELIX       433    435       {ECO:0000244|PDB:3V5W}.
FT   STRAND      440    442       {ECO:0000244|PDB:3V5W}.
FT   HELIX       444    447       {ECO:0000244|PDB:3V5W}.
FT   HELIX       451    453       {ECO:0000244|PDB:3V5W}.
FT   HELIX       458    462       {ECO:0000244|PDB:3V5W}.
FT   HELIX       500    503       {ECO:0000244|PDB:3V5W}.
FT   TURN        504    508       {ECO:0000244|PDB:3V5W}.
FT   HELIX       514    522       {ECO:0000244|PDB:3V5W}.
FT   TURN        523    525       {ECO:0000244|PDB:3V5W}.
FT   HELIX       526    546       {ECO:0000244|PDB:3V5W}.
FT   STRAND      555    557       {ECO:0000244|PDB:3V5W}.
FT   STRAND      561    568       {ECO:0000244|PDB:3V5W}.
FT   HELIX       571    573       {ECO:0000244|PDB:4MK0}.
FT   STRAND      577    584       {ECO:0000244|PDB:3V5W}.
FT   STRAND      587    591       {ECO:0000244|PDB:3V5W}.
FT   STRAND      593    595       {ECO:0000244|PDB:4MK0}.
FT   STRAND      599    602       {ECO:0000244|PDB:3V5W}.
FT   HELIX       603    605       {ECO:0000244|PDB:3V5W}.
FT   STRAND      606    616       {ECO:0000244|PDB:3V5W}.
FT   STRAND      618    624       {ECO:0000244|PDB:3V5W}.
FT   TURN        625    627       {ECO:0000244|PDB:3V5W}.
FT   STRAND      628    633       {ECO:0000244|PDB:3V5W}.
FT   HELIX       637    658       {ECO:0000244|PDB:3V5W}.
FT   TURN        662    664       {ECO:0000244|PDB:3V5W}.
SQ   SEQUENCE   689 AA;  79574 MW;  4DB68F62841AFA7D CRC64;
     MADLEAVLAD VSYLMAMEKS KATPAARASK KILLPEPSIR SVMQKYLEDR GEVTFEKIFS
     QKLGYLLFRD FCLNHLEEAR PLVEFYEEIK KYEKLETEEE RVARSREIFD SYIMKELLAC
     SHPFSKSATE HVQGHLGKKQ VPPDLFQPYI EEICQNLRGD VFQKFIESDK FTRFCQWKNV
     ELNIHLTMND FSVHRIIGRG GFGEVYGCRK ADTGKMYAMK CLDKKRIKMK QGETLALNER
     IMLSLVSTGD CPFIVCMSYA FHTPDKLSFI LDLMNGGDLH YHLSQHGVFS EADMRFYAAE
     IILGLEHMHN RFVVYRDLKP ANILLDEHGH VRISDLGLAC DFSKKKPHAS VGTHGYMAPE
     VLQKGVAYDS SADWFSLGCM LFKLLRGHSP FRQHKTKDKH EIDRMTLTMA VELPDSFSPE
     LRSLLEGLLQ RDVNRRLGCL GRGAQEVKES PFFRSLDWQM VFLQKYPPPL IPPRGEVNAA
     DAFDIGSFDE EDTKGIKLLD SDQELYRNFP LTISERWQQE VAETVFDTIN AETDRLEARK
     KAKNKQLGHE EDYALGKDCI MHGYMSKMGN PFLTQWQRRY FYLFPNRLEW RGEGEAPQSL
     LTMEEIQSVE ETQIKERKCL LLKIRGGKQF ILQCDSDPEL VQWKKELRDA YREAQQLVQR
     VPKMKNKPRS PVVELSKVPL VQRGSANGL
//
